Molnupiravir

Over the past year, discussions—sometimes heated ones—about ending the COVID-19 pandemic have largely focused on the availability, effectiveness, and safety of vaccines. But in December 2021, the Food and Drug Administration (FDA) issued emergency use authorizations (EUAs) for two pills that patients can take at home in the days after COVID-19 symptoms arise to prevent severe disease and avoid going to the hospital